s
EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data
In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
5
举报
登录后可参与评论

暂无评论
s
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。